nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Oedema—Fludarabine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cyproterone acetate—Decreased appetite—Teniposide—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cyproterone acetate—Renal failure—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cyproterone acetate—Vomiting—Mechlorethamine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Cyproterone acetate—Rash—Mechlorethamine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cyproterone acetate—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cyproterone acetate—Weight decreased—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Cyproterone acetate—Anorexia—Fludarabine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cyproterone acetate—Weight increased—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cyproterone acetate—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Teniposide—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Cyproterone acetate—Chills—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cyproterone acetate—Skin discolouration—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cyproterone acetate—Sweating—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cyproterone acetate—Renal failure—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cyproterone acetate—Nausea—Mechlorethamine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Cyproterone acetate—Alopecia—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Cyproterone acetate—Jaundice—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Cyproterone acetate—Haemoglobin—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cyproterone acetate—Urticaria—Teniposide—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cyproterone acetate—Glossitis—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cyproterone acetate—Haemorrhage—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cyproterone acetate—Abdominal pain—Teniposide—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cyproterone acetate—Body temperature increased—Teniposide—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cyproterone acetate—Sweating—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cyproterone acetate—Dyspnoea—Fludarabine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cyproterone acetate—Haematuria—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cyproterone acetate—Dyspepsia—Fludarabine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cyproterone acetate—Decreased appetite—Fludarabine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Cyproterone acetate—Visual impairment—Carmustine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cyproterone acetate—Fatigue—Fludarabine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cyproterone acetate—Constipation—Fludarabine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cyproterone acetate—Eye disorder—Carmustine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cyproterone acetate—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Teniposide—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cyproterone acetate—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cyproterone acetate—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Cyproterone acetate—Anaemia—Bleomycin—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cyproterone acetate—Asthenia—Teniposide—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Cyproterone acetate—Malaise—Bleomycin—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Cyproterone acetate—Pruritus—Teniposide—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Cyproterone acetate—Leukopenia—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cyproterone acetate—Alopecia—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cyproterone acetate—Body temperature increased—Fludarabine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cyproterone acetate—Mental disorder—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cyproterone acetate—Malnutrition—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cyproterone acetate—Cough—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cyproterone acetate—Angiopathy—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Cyproterone acetate—Diarrhoea—Teniposide—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cyproterone acetate—Alopecia—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cyproterone acetate—Coma—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cyproterone acetate—Discomfort—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cyproterone acetate—Mental disorder—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cyproterone acetate—Chills—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cyproterone acetate—Neoplasm—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Cyproterone acetate—Alopecia—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Cyproterone acetate—Oedema—Bleomycin—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cyproterone acetate—Anaemia—Carmustine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cyproterone acetate—Vomiting—Teniposide—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cyproterone acetate—Agitation—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cyproterone acetate—Asthenia—Fludarabine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cyproterone acetate—Rash—Teniposide—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cyproterone acetate—Dermatitis—Teniposide—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cyproterone acetate—Headache—Teniposide—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cyproterone acetate—Pruritus—Fludarabine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Cyproterone acetate—Leukopenia—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Cyproterone acetate—Anorexia—Bleomycin—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cyproterone acetate—Anaemia—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cyproterone acetate—Agitation—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cyproterone acetate—Hypotension—Bleomycin—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Cyproterone acetate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Cyproterone acetate—Nausea—Teniposide—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Cyproterone acetate—Anaemia—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Cyproterone acetate—Hepatic failure—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Cyproterone acetate—Leukopenia—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Cyproterone acetate—Malaise—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cyproterone acetate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cyproterone acetate—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cyproterone acetate—Oedema—Carmustine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cyproterone acetate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cyproterone acetate—Cough—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cyproterone acetate—Vomiting—Fludarabine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cyproterone acetate—Rash—Fludarabine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Cyproterone acetate—Dermatitis—Fludarabine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cyproterone acetate—Headache—Fludarabine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cyproterone acetate—Tachycardia—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Cyproterone acetate—Discomfort—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Cyproterone acetate—Oedema—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cyproterone acetate—Anorexia—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cyproterone acetate—Hypotension—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cyproterone acetate—Oedema—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cyproterone acetate—Nausea—Fludarabine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cyproterone acetate—Shock—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cyproterone acetate—Urticaria—Bleomycin—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cyproterone acetate—Anorexia—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cyproterone acetate—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cyproterone acetate—Body temperature increased—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cyproterone acetate—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cyproterone acetate—Mood swings—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cyproterone acetate—Hypotension—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cyproterone acetate—Dyspnoea—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cyproterone acetate—Anorexia—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cyproterone acetate—Decreased appetite—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cyproterone acetate—Hypotension—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cyproterone acetate—Constipation—Carmustine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cyproterone acetate—Breast disorder—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cyproterone acetate—Decreased appetite—Vincristine—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Cyproterone acetate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000992	0.000992	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Carmustine—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Cyproterone acetate—Fatigue—Vincristine—lymphatic system cancer	0.000985	0.000985	CcSEcCtD
Cyproterone acetate—Asthenia—Bleomycin—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Cyproterone acetate—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Cyproterone acetate—Constipation—Vincristine—lymphatic system cancer	0.000977	0.000977	CcSEcCtD
Cyproterone acetate—Asthma—Methotrexate—lymphatic system cancer	0.000975	0.000975	CcSEcCtD
Cyproterone acetate—Pruritus—Bleomycin—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Cyproterone acetate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000968	0.000968	CcSEcCtD
Cyproterone acetate—Fatigue—Mitoxantrone—lymphatic system cancer	0.00096	0.00096	CcSEcCtD
Cyproterone acetate—Pancreatitis—Methotrexate—lymphatic system cancer	0.000956	0.000956	CcSEcCtD
Cyproterone acetate—Constipation—Mitoxantrone—lymphatic system cancer	0.000952	0.000952	CcSEcCtD
Cyproterone acetate—Abdominal pain—Carmustine—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Cyproterone acetate—Body temperature increased—Carmustine—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000935	0.000935	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000917	0.000917	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Cyproterone acetate—Abdominal pain—Vincristine—lymphatic system cancer	0.000904	0.000904	CcSEcCtD
Cyproterone acetate—Body temperature increased—Vincristine—lymphatic system cancer	0.000904	0.000904	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000898	0.000898	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00089	0.00089	CcSEcCtD
Cyproterone acetate—Urticaria—Mitoxantrone—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Carmustine—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Cyproterone acetate—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Cyproterone acetate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Cyproterone acetate—Vomiting—Bleomycin—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Cyproterone acetate—Rash—Bleomycin—lymphatic system cancer	0.000865	0.000865	CcSEcCtD
Cyproterone acetate—Dermatitis—Bleomycin—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Cyproterone acetate—Asthenia—Carmustine—lymphatic system cancer	0.000859	0.000859	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Vincristine—lymphatic system cancer	0.000842	0.000842	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—lymphatic system cancer	0.000834	0.000834	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000822	0.000822	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00082	0.00082	CcSEcCtD
Cyproterone acetate—Asthenia—Vincristine—lymphatic system cancer	0.00082	0.00082	CcSEcCtD
Cyproterone acetate—Diarrhoea—Carmustine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Cyproterone acetate—Nausea—Bleomycin—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Cyproterone acetate—Asthenia—Mitoxantrone—lymphatic system cancer	0.000799	0.000799	CcSEcCtD
Cyproterone acetate—Dizziness—Carmustine—lymphatic system cancer	0.000792	0.000792	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—lymphatic system cancer	0.000785	0.000785	CcSEcCtD
Cyproterone acetate—Diarrhoea—Vincristine—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Cyproterone acetate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000762	0.000762	CcSEcCtD
Cyproterone acetate—Vomiting—Carmustine—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Cyproterone acetate—Dizziness—Vincristine—lymphatic system cancer	0.000756	0.000756	CcSEcCtD
Cyproterone acetate—Rash—Carmustine—lymphatic system cancer	0.000755	0.000755	CcSEcCtD
Cyproterone acetate—Dermatitis—Carmustine—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—lymphatic system cancer	0.000752	0.000752	CcSEcCtD
Cyproterone acetate—Headache—Carmustine—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000738	0.000738	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Cyproterone acetate—Vomiting—Vincristine—lymphatic system cancer	0.000727	0.000727	CcSEcCtD
Cyproterone acetate—Rash—Vincristine—lymphatic system cancer	0.000721	0.000721	CcSEcCtD
Cyproterone acetate—Dermatitis—Vincristine—lymphatic system cancer	0.00072	0.00072	CcSEcCtD
Cyproterone acetate—Headache—Vincristine—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Cyproterone acetate—Nausea—Carmustine—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Cyproterone acetate—Vomiting—Mitoxantrone—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000704	0.000704	CcSEcCtD
Cyproterone acetate—Rash—Mitoxantrone—lymphatic system cancer	0.000702	0.000702	CcSEcCtD
Cyproterone acetate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Cyproterone acetate—Headache—Mitoxantrone—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—lymphatic system cancer	0.000684	0.000684	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Cyproterone acetate—Nausea—Vincristine—lymphatic system cancer	0.000679	0.000679	CcSEcCtD
Cyproterone acetate—Nausea—Mitoxantrone—lymphatic system cancer	0.000661	0.000661	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000631	0.000631	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—lymphatic system cancer	0.000628	0.000628	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—lymphatic system cancer	0.000613	0.000613	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—lymphatic system cancer	0.000593	0.000593	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000575	0.000575	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000544	0.000544	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000543	0.000543	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—lymphatic system cancer	0.000539	0.000539	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000536	0.000536	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—lymphatic system cancer	0.000529	0.000529	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—lymphatic system cancer	0.000518	0.000518	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—lymphatic system cancer	0.000494	0.000494	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—lymphatic system cancer	0.000488	0.000488	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—lymphatic system cancer	0.000482	0.000482	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000479	0.000479	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—lymphatic system cancer	0.000478	0.000478	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000457	0.000457	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000454	0.000454	CcSEcCtD
Cyproterone acetate—Urticaria—Methotrexate—lymphatic system cancer	0.000441	0.000441	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—lymphatic system cancer	0.000438	0.000438	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—lymphatic system cancer	0.000438	0.000438	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000409	0.000409	CcSEcCtD
Cyproterone acetate—Asthenia—Methotrexate—lymphatic system cancer	0.000398	0.000398	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—lymphatic system cancer	0.000379	0.000379	CcSEcCtD
Cyproterone acetate—Dizziness—Methotrexate—lymphatic system cancer	0.000367	0.000367	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—lymphatic system cancer	0.000353	0.000353	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—lymphatic system cancer	0.00035	0.00035	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—lymphatic system cancer	0.000349	0.000349	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—lymphatic system cancer	0.000347	0.000347	CcSEcCtD
Cyproterone acetate—Nausea—Methotrexate—lymphatic system cancer	0.000329	0.000329	CcSEcCtD
